洁特生物
(688026)
| 流通市值：18.82亿 | | | 总市值：18.84亿 |
| 流通股本：1.40亿 | | | 总股本：1.40亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 390,816,368.3 | 236,248,436.02 | 98,275,342.97 | 463,097,581.69 |
| 营业收入 | 390,816,368.3 | 236,248,436.02 | 98,275,342.97 | 463,097,581.69 |
| 二、营业总成本 | 329,050,630.04 | 205,718,677.24 | 93,172,588.62 | 419,977,982.61 |
| 营业成本 | 235,334,231.66 | 147,305,654.96 | 66,900,741.91 | 321,287,263.34 |
| 税金及附加 | 7,735,336.14 | 2,499,119.27 | 1,087,571.51 | 6,779,879.54 |
| 销售费用 | 20,852,942.24 | 14,772,268.97 | 5,948,958.13 | 30,178,445.07 |
| 管理费用 | 28,509,529.84 | 19,600,168.71 | 8,358,576.89 | 28,150,128.12 |
| 研发费用 | 19,834,731.06 | 13,274,839.95 | 6,497,446.91 | 28,506,821.17 |
| 财务费用 | 16,783,859.1 | 8,266,625.38 | 4,379,293.27 | 5,075,445.37 |
| 其中:利息费用 | 19,763,820.22 | 13,084,794.61 | 6,510,761.98 | 24,794,716.04 |
| 其中:利息收入 | 8,672,495.16 | 5,616,841.9 | 3,366,317.33 | 14,376,498.53 |
| 加:投资收益 | -395,165.62 | -309,911.96 | -298,601.96 | -796,036.7 |
| 资产处置收益 | -167,342.79 | 17,583.23 | 17,583.23 | -1,704,571.45 |
| 资产减值损失(新) | -7,816,364.19 | - | -192,110.47 | -6,426,687.86 |
| 信用减值损失(新) | -1,222,040.64 | 185,521.24 | 482,012.62 | -2,953,799.81 |
| 其他收益 | 8,721,963.78 | 6,361,703.93 | 5,042,418.04 | 8,204,819.4 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 60,886,788.8 | 36,784,655.22 | 10,154,055.81 | 39,443,322.66 |
| 加:营业外收入 | 6,748.88 | 6,208.86 | 54,700.73 | 61,921.39 |
| 减:营业外支出 | 134,857.21 | 134,657.26 | 66,883.56 | 1,185,283.66 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 60,758,680.47 | 36,656,206.82 | 10,141,872.98 | 38,319,960.39 |
| 减:所得税费用 | 10,420,757.96 | 6,570,110.5 | 1,929,238.77 | 3,221,267.11 |
| 六、净利润 | 50,337,922.51 | 30,086,096.32 | 8,212,634.21 | 35,098,693.28 |
| 持续经营净利润 | 50,337,922.51 | 30,086,096.32 | 8,212,634.21 | 35,098,693.28 |
| 归属于母公司股东的净利润 | 50,156,789.96 | 30,000,204.54 | 8,178,548.18 | 34,788,457.58 |
| 少数股东损益 | 181,132.55 | 85,891.78 | 34,086.03 | 310,235.7 |
| (一)基本每股收益 | 0.41 | 0.23 | 0.07 | 0.25 |
| (二)稀释每股收益 | 0.41 | 0.23 | 0.07 | 0.25 |
| 八、其他综合收益 | 87,520.41 | -76,661.71 | -55,446.63 | 372,375.73 |
| 归属于母公司股东的其他综合收益 | 87,520.41 | -76,661.71 | -55,446.63 | 372,375.73 |
| 九、综合收益总额 | 50,425,442.92 | 30,009,434.61 | 8,157,187.58 | 35,471,069.01 |
| 归属于母公司股东的综合收益总额 | 50,244,310.37 | 29,923,542.83 | 8,123,101.55 | 35,160,833.31 |
| 归属于少数股东的综合收益总额 | 181,132.55 | 85,891.78 | 34,086.03 | 310,235.7 |
| 公告日期 | 2024-10-24 | 2024-08-24 | 2024-04-27 | 2024-04-20 |
| 审计意见(境内) | | | | 标准无保留意见 |